Astellas   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Tokyo Japan (2005)
Status: Acquired by Leo Pharma (2015)

Organization Overview

First Clinical Trial
2005
NCT00150891
First Marketed Drug
2005
triamcinolone (kenalog)
First NDA Approval
2005
conivaptan (vaprisol)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

APGDI | APGD, Medical Affairs, Americas | Astellas, | ASTELLAS | Astellas Global Development | Astellas Institute for Regenerative Medicine | Astellas Medical Affairs, Americas | Astellas Phama Global Development | Astellas Pharma BV | Astellas Pharma Canada, Inc. | Astellas Pharma China, Inc. | Astellas Pharma Clinical Pharmacology & Exploratory Dev. | Astellas Pharma Co. Ltd (APCL) | Astellas Pharma Europe B.V. | Astellas Pharma Europe BV (APEB) | Astellas Pharma Europe Limited | Astellas Pharma Europe Ltd. | Astellas Pharma Global Development | Astellas Pharma Global Development - EU | Astellas Pharma Global Development, Inc. | Astellas Pharma Global Development, Inc. (APGD) | Astellas Pharma Global Development, Inc., Medical Affairs, Americas | Astellas Pharma GmbH | Astellas Pharma Inc | Astellas Pharma Inc., Japan | Astellas Pharma Indonesia | Astellas Pharma Indonesia Inc. | Astellas Pharma Korea, Inc. | Astellas Pharma Russian affiliate | Astellas Pharma S.A.S. | Astellas Pharma Singapore Pte. Ltd. | Astellas Pharma s.r.o. | Astellas Pharma Taiwan, Inc. | Astellas Pharma US, Inc. | Astellas Pharm. Inc. | Astellas Scientific & Medical Affairs, Inc. | Clinical Development Administration Dept., Astellas Pharma Inc. | Clinical Development, Astellas Pharma Inc. | Clinical Development III, Astellas Pharm. Inc. | Medical Affairs Europe, Astellas Pharma Europe Limited Hillswood Drive | Medical Affairs Europe, Astellas Pharma Europe Limited, Lovett House, Lovett Road, Staines Middlesex TW 18 3AZ | Si Pharmaceuticals | SI PHARMS | ZAO Astellas Pharma Russia